| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.047 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |